Novo Holdings invests in three more AMR biotechsNovo Holdings’ REPAIR Impact Fund, which helps fund companies tackling antimicrobial resistance (AMR), has announced three new investments. Share XNovo Holdings invests in three more AMR biotechshttps://pharmaphorum.com/news/novo-holdings-invests-in-three-more-amr-biotechs/
FDA approves Samsung/Merck & Co’s Herceptin biosimilarThe FDA has approved a new biosimilar of Roche’s breast cancer drug Herceptin, from Samsung Bioepis and Merck Share XFDA approves Samsung/Merck & Co’s Herceptin biosimilarhttps://pharmaphorum.com/news/fda-approves-samsung-merck-cos-herceptin-biosimilar/
AbbVie and J&J’s Imbruvica fails pancreatic cancer testAbbVie and Johnson & Johnson’s hopes of adding pancreatic cancer to the repertoire of oncology blockbuster Imbruvica has Share XAbbVie and J&J’s Imbruvica fails pancreatic cancer testhttps://pharmaphorum.com/news/abbvie-and-jjs-imbruvica-fails-pancreatic-cancer-test/
Alphabet’s smart watch ECG gets FDA backingAlphabet’s life science subsidiary Verily is the latest firm to get an electrocardiogram (ECG) watch approved by the Share XAlphabet’s smart watch ECG gets FDA backinghttps://pharmaphorum.com/news/alphabets-smart-watch-ecg-gets-fda-backing/
Court backs NHS in hepatitis C procurement row with AbbVieA court has backed NHS England in a case where US pharma giant AbbVie had alleged that its Share XCourt backs NHS in hepatitis C procurement row with AbbViehttps://pharmaphorum.com/news/court-backs-nhs-in-hepatitis-c-procurement-row-with-abbvie/
NHS faces uphill battle in prevention – surveyA new survey has revealed confusion amongst the UK public on how to maintain a healthy lifestyle, suggesting Share XNHS faces uphill battle in prevention – surveyhttps://pharmaphorum.com/news/nhs-uphill-battle-prevention-survey/
GSK’s chairman Sir Philip Hampton steps downGlaxoSmithKline is searching for a new chairman after Sir Philip Hampton announced he is to step down in Share XGSK’s chairman Sir Philip Hampton steps downhttps://pharmaphorum.com/news/gsks-chairman-sir-philip-hampton-steps-down/
Celgene signs brace of immuno-oncology deals with US biotechsDespite a looming takeover by Bristol-Myers Squibb, Celgene hasn’t stopped making pipeline-boosting deals. It’s just added two more Share XCelgene signs brace of immuno-oncology deals with US biotechshttps://pharmaphorum.com/news/celgene-signs-brace-of-immuno-oncology-deals-with-us-biotechs/
Lilly stops promoting cancer drug after shock trial failureShares in Eli Lilly were down in early trading after the US drugmaker said its cancer drug Lartruvo Share XLilly stops promoting cancer drug after shock trial failurehttps://pharmaphorum.com/news/lilly-pulls-cancer-drug-from-market-after-shock-trial-failure/
FDA decisions could ‘slow to crawl’ because of government shutdownExperts have said the ongoing government shutdown may already have delayed approval and launch of new drugs, as Share XFDA decisions could ‘slow to crawl’ because of government shutdownhttps://pharmaphorum.com/news/fda-decisions-could-slow-to-crawl-because-of-government-shutdown/
FDA advisers divided on Sanofi’s oral type 1 diabetes drugThe future of Sanofi and Lexicon’s oral diabetes drug Zynquista hangs in the balance after an FDA advisory Share XFDA advisers divided on Sanofi’s oral type 1 diabetes drughttps://pharmaphorum.com/news/fda-divided-on-sanofis-oral-type-1-diabetes-drug/
Novartis and Oxford University begin R&D tie-upNovartis and Oxford University have begun a partnership that will attempt to use artificial intelligence to predict how Share XNovartis and Oxford University begin R&D tie-uphttps://pharmaphorum.com/news/novartis-and-oxford-university-begin-rd-tie-up/
J&J partners with Apple for ECG monitoring projectApple has a new big pharma partner to help put its new Apple Watch with built-in electrocardiogram (ECG) Share XJ&J partners with Apple for ECG monitoring projecthttps://pharmaphorum.com/news/jj-partners-with-apple-for-ecg-monitoring-project/
Communiqué Awards 2019 opens for healthcare comms entriesThe Communiqué Awards 2019 have launched, seeking entries in European, international and local healthcare communications. The UK-based med Share XCommuniqué Awards 2019 opens for healthcare comms entrieshttps://pharmaphorum.com/news/communique-awards-2019-launch/
Telehealth firm secures more cash to expand in China, Japan and USTelehealth firm Tyto Care has secured additional funding to help with the launch of its technology allowing for Share XTelehealth firm secures more cash to expand in China, Japan and UShttps://pharmaphorum.com/news/telehealth-firm-secures-more-cash-to-expand-in-china-japan-and-us/
FDA advisers back Amgen/UCB’s osteoporosis drug EvenityAmgen’s bone-building drug Evenity looks on course for US approval in certain women with osteoporosis after a panel Share XFDA advisers back Amgen/UCB’s osteoporosis drug Evenityhttps://pharmaphorum.com/news/fda-advisers-back-amgen-ucbs-osteoporosis-drug-evenity/
Lilly’s Verzenios approved by NICENICE has published draft guidance that now recommends Eli Lilly’s breast cancer drug Verzenios for use on the Share XLilly’s Verzenios approved by NICEhttps://pharmaphorum.com/news/lillys-verzenios-approved-nice/
UK researchers investigate alternatives to long-term opioid useA UK university has been awarded £2.4 million to research overprescribing of opioids, and how to improve treatment Share XUK researchers investigate alternatives to long-term opioid usehttps://pharmaphorum.com/news/uk-researchers-investigate-alternatives-to-long-term-opioid-use/
Invite from Roderick Hubbard, Vernalis Research chairing SMi’s Drug Discovery Conference Share XInvite from Roderick Hubbard, Vernalis Research chairing SMi’s Drug Discovery Conferencehttps://pharmaphorum.com/partner-content/invite-from-roderick-hubbard-vernalis-research-chairing-smis-drug-discovery-conference/
Pharmaceutical Microbiology UK CONFEX takes place in less than a week! Share XPharmaceutical Microbiology UK CONFEX takes place in less than a week!https://pharmaphorum.com/partner-content/pharmaceutical-microbiology-uk-confex-takes-place-in-less-than-a-week/
Tom Parke to lead a workshop on the new FDA draft guidance Share XTom Parke to lead a workshop on the new FDA draft guidancehttps://pharmaphorum.com/partner-content/tom-parke-to-lead-a-workshop-on-the-new-fda-draft-guidance/
Three-dimensional cell cultures as predictive tools in early drug discovery Share XThree-dimensional cell cultures as predictive tools in early drug discoveryhttps://pharmaphorum.com/partner-content/three-dimensional-cell-cultures-as-predictive-tools-in-early-drug-discovery/
pharmaphorum welcomes George Underwood to its editorial helm Share Xpharmaphorum welcomes George Underwood to its editorial helmhttps://pharmaphorum.com/news/pharmaphorum-welcomes-george-underwood-to-its-editorial-helm/
STEM Healthcare appoints Jason McKenna as CEO Share XSTEM Healthcare appoints Jason McKenna as CEOhttps://pharmaphorum.com/partner-content/stem-healthcare-appoints-jason-mckenna-as-ceo/
